Sprint Challenge Description
On behalf of a coalition of industry and government sponsors, TechConnect Ventures is seeking immediate responses demonstrating technologies which can improve the delivery of oxygen therapy or supplemental oxygen in home use and other non-intensive care environments. Responses to this Sprint may describe technological enhancements to address a range of factors that limit currently available oxygen delivery solutions, such as system portability, oxygen flow rate, monitoring, and delivery system autonomy. Solutions from organizations of all types are invited, including academia, research, start-ups, small-to-medium enterprise and more.
Top technologies will be considered for both current and future development, funding, licensing and acquisition Opportunities by TechConnect Ventures' diverse cross-section of Sprint sponsors, including frontline organizations and their partners. Certain top technologies will also be featured in an upcoming COVID-19 Innovation Opportunity Report which will be promoted across all of TechConnect Ventures' corporate, agency and investment partners.
Why are we running this Sprint?
Many of the primary and most debilitating symptoms of COVID-19 are respiratory in nature, ranging from mild shortness of breath to severe acute respiratory distress syndrome. The prevalence of respiratory symptoms beyond the course of initial infection and recovery have been shown in certain cases to last from weeks to months or longer. For many recovering COVID-19 patients, the availability of reliable, effective oxygen treatment technologies may represent a critical component to maintaining stable quality of life.
Current evidence suggests that home oxygen therapy technologies and other options for supplemental oxygen treatment are currently insufficient to meet the complexity of demand. Issues exist with regards to both form and function of existing systems, such as:
The goal of this Sprint is to accelerate new solutions to fill these glaring technological gaps, by identifying innovations that can transform the future of supplemental oxygen delivery, including devices, materials, designs, processes, power systems, hardware and software.
TechConnect Ventures invites any and all responses describing innovations to drive the next generation of oxygen delivery technologies. This includes innovations that will address areas such as lightweight and small footprint technologies, improved capacity, physiological sensors for physical activity and breathing, predictors of oxygen desaturation, and/or innovations for more precise, intelligent and tunable oxygen delivery in home-use/self-managed environments (including autonomous systems).
TechConnect Ventures is seeking partners from all industries and disciplines to propose solutions. Any and all novel potential technologies that can be used to create oxygen delivery solutions are of interest for this Sprint.
All Submissions must include a completed Submission Webform (link). Submit only NON-CONFIDENTIAL information.
Within the Submission Webform your Entry should address the Problem Statement through the following:
Respondents are also invited to upload one (1) supplemental file (max. size 10MB) containing their unique technology pitch, presentation or white paper summary.
TechConnect Ventures and the members of its COVID-19 coalition will review all submissions within 4-6 weeks of the Submission Deadline. Based on the nature of the innovation and strength of the response relative to all submissions received, top innovators may be selected for further discussions, pitches or proposals which may lead to contractual or commercial engagements for the research, development or commercialization of the most promising technologies.
Contact email@example.com and reference the Sprint Topic.
PARTICIPATION RULES & GUIDELINES
QUESTIONS? Contact Executive Director, Nick Kacsandi at firstname.lastname@example.org